SEC Form 4 · accession 0000914190-17-000221
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Gillund
Officer — Chief Talent Officer
Period of report
Aug 7, 2017
Accepted (ET)
Aug 9, 2017 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 7, 2017 | A | 5,038 | $0.00 | A | 75,870 | D | |
| Common StockF3 | Aug 7, 2017 | A | 15,113 | $0.00 | A | 90,983 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restrictions lapse as to 1,680 shares on 8/13/18 and 1,679 shares on each of 8/13/19 and 8/13/20.
- F2Includes 339 shares acquired on December 31, 2016 and 952 shares acquired on June 30, 2017 through the Issuer's Employee Stock Purchase Plan.
- F3Subject to performance-based forfeiture based on the three year total shareholder return for fiscal years 2018, 2019 and 2020 versus the Company's peer group.